The landscape of dementia diagnosis has evolved drastically with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent assessments that could detect Alzheimer's pathology a long time just before signs emerge. Though these technological advancements depict amazing progress in understanding neurodegenerative diseases, they have not https://neilt827czk8.gigswiki.com/user